How severe is CVE-2025-36228?

CVE-2025-36228 has a CVSS 3.x base score of 3.8, rated low severity. It is exploitable over network with low attack complexity, requires high privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability none.

Is CVE-2025-36228 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (10th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2025-36228?

CVE-2025-36228 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2025-36228?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2025-36228 have an EU (EUVD) identifier?

Yes. CVE-2025-36228 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-205441.

When was CVE-2025-36228 published?

CVE-2025-36228 was published on 2025-12-26 and last updated on 2026-06-17.

CVE-2025-36228

CVE-2025-36228 is a low-severity vulnerability in Ibm Aspera Faspex with a CVSS 3.x base score of 3.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-279.

Key facts

Severity: Low (CVSS 3.x base score 3.8)
EPSS exploit prediction: 0% (10th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2025-205441
Weakness: CWE-279
Affected product: Ibm Aspera Faspex
Published: 2025-12-26
Last modified: 2026-06-17

Description

IBM Aspera Faspex 5 5.0.0 through 5.0.14.1 may allow inconsistent permissions between the user interface and backend API allowed users to access features that appeared disabled, potentially leading to misuse.

Frequently asked questions

What is CVE-2025-36228?: IBM Aspera Faspex 5 5.0.0 through 5.0.14.1 may allow inconsistent permissions between the user interface and backend API allowed users to access features that appeared disabled, potentially leading to misuse.
How severe is CVE-2025-36228?: CVE-2025-36228 has a CVSS 3.x base score of 3.8, rated low severity. It is exploitable over network with low attack complexity, requires high privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2025-36228 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (10th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2025-36228?: CVE-2025-36228 affects Ibm Aspera Faspex. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2025-36228?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2025-36228 have an EU (EUVD) identifier?: Yes. CVE-2025-36228 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-205441.
When was CVE-2025-36228 published?: CVE-2025-36228 was published on 2025-12-26 and last updated on 2026-06-17.

References

https://www.ibm.com/support/pages/node/7255331

Affected products (1)

cpe:2.3:a:ibm:aspera_faspex:*:*:*:*:*:*:*:*

More vulnerabilities in Ibm Aspera Faspex

CVE-2023-27874 — Critical (CVSS 9.9): IBM Aspera Faspex 4.4.2 is vulnerable to an XML external entity injection (XXE) attack when processing XML data. A…
CVE-2022-47986 — Critical (CVSS 9.8): IBM Aspera Faspex 4.4.2 Patch Level 1 and earlier could allow a remote attacker to execute arbitrary code on the…
CVE-2023-37400 — High (CVSS 7.8): IBM Aspera Faspex 5.0.0 through 5.0.7 could allow a local user to escalate their privileges due to insecure credential…
CVE-2023-30995 — High (CVSS 7.5): IBM Aspera Faspex 4.0 through 4.4.2 and 5.0 through 5.0.5 could allow a malicious actor to bypass IP whitelist…
CVE-2023-27871 — High (CVSS 7.5): IBM Aspera Faspex 4.4.2 could allow a remote attacker to obtain sensitive credential information for an external user,…
CVE-2023-27875 — High (CVSS 7.5): IBM Aspera Faspex 5.0.4 could allow a user to change other user's credentials due to improper access controls. IBM…

All CVEs affecting Ibm Aspera Faspex →

Other CWE-279 vulnerabilities

CVE-2024-37734 — Critical (CVSS 9.8): An issue in OpenEMR 7.0.2 allows a remote attacker to escalate privileges viaa crafted POST request using the noteid…
CVE-2025-14025 — High (CVSS 8.5): A flaw was found in Ansible Automation Platform (AAP). Read-only scoped OAuth2 API Tokens in AAP, are enforced at the…
CVE-2025-22843 — High (CVSS 7.8): Incorrect execution-assigned permissions for some Edge Orchestrator software for Intel(R) Tiber™ Edge Platform may…
CVE-2025-23263 — High (CVSS 7.6): NVIDIA DOCA-Host and Mellanox OFED contain a vulnerability in the VGT+ feature, where an attacker on a VM might cause…
CVE-2024-25621 — High (CVSS 7.3): containerd is an open-source container runtime. Versions 0.1.0 through 1.7.28, 2.0.0-beta.0 through 2.0.6, 2.1.0-beta.0…
CVE-2025-30001 — High (CVSS 7.3): Incorrect Execution-Assigned Permissions vulnerability in Apache StreamPark. This issue affects Apache StreamPark:…

Browse all CWE-279 vulnerabilities →